| Secondary bile acids: an underrecognized cause of colon cancer H Ajouz, D Mukherji, A Shamseddine World journal of surgical oncology 12, 1-5, 2014 | 410 | 2014 |
| Resistance mechanisms to anti-angiogenic therapies in cancer Y Haibe, M Kreidieh, H El Hajj, I Khalifeh, D Mukherji, S Temraz, ... Frontiers in oncology 10, 221, 2020 | 262 | 2020 |
| Visceral disease in castration-resistant prostate cancer CJ Pezaro, A Omlin, D Lorente, DN Rodrigues, R Ferraldeschi, ... European urology 65 (2), 270-273, 2014 | 237 | 2014 |
| Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells HF Bahmad, K Cheaito, RM Chalhoub, O Hadadeh, A Monzer, F Ballout, ... Frontiers in oncology 8, 347, 2018 | 177 | 2018 |
| Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018 A Shamseddine, A Saleh, M Charafeddine, M Seoud, D Mukherji, ... Population health metrics 12, 1-8, 2014 | 164 | 2014 |
| Update on totally implantable venous access devices A Zaghal, M Khalife, D Mukherji, N El Majzoub, A Shamseddine, ... Surgical oncology 21 (3), 207-215, 2012 | 128 | 2012 |
| Dual inhibition of MEK and PI3K pathway in KRAS and BRAF mutated colorectal cancers S Temraz, D Mukherji, A Shamseddine International journal of molecular sciences 16 (9), 22976-22988, 2015 | 117 | 2015 |
| Gut microbiome: a promising biomarker for immunotherapy in colorectal cancer S Temraz, F Nassar, R Nasr, M Charafeddine, D Mukherji, ... International journal of molecular sciences 20 (17), 4155, 2019 | 116 | 2019 |
| An analysis of contemporary oncology randomized clinical trials from low/middle-income vs high-income countries JC Wells, S Sharma, JC Del Paggio, WM Hopman, B Gyawali, D Mukherji, ... JAMA oncology 7 (3), 379-385, 2021 | 104 | 2021 |
| Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms A Omlin, C Pezaro, D Mukherji, AM Cassidy, S Sandhu, D Bianchini, ... European urology 64 (2), 300-306, 2013 | 94 | 2013 |
| Potential targets for colorectal cancer prevention S Temraz, D Mukherji, A Shamseddine International journal of molecular sciences 14 (9), 17279-17303, 2013 | 93 | 2013 |
| First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate … D Bianchini, A Omlin, C Pezaro, D Lorente, R Ferraldeschi, D Mukherji, ... British journal of cancer 109 (10), 2579-2586, 2013 | 89 | 2013 |
| Auxiliary liver transplantation for acute liver failure in children W Faraj, F Dar, A Bartlett, HV Melendez, G Marangoni, D Mukherji, ... Annals of surgery 251 (2), 351-356, 2010 | 87 | 2010 |
| Exosomal non coding RNA in LIQUID biopsies as a promising biomarker for colorectal cancer A Baassiri, F Nassar, D Mukherji, A Shamseddine, R Nasr, S Temraz International journal of molecular sciences 21 (4), 1398, 2020 | 86 | 2020 |
| Methods of overcoming treatment resistance in colorectal cancer S Temraz, D Mukherji, R Alameddine, A Shamseddine Critical reviews in oncology/hematology 89 (2), 217-230, 2014 | 82 | 2014 |
| Anxiety, depression and quality of life in breast cancer patients in the levant R Akel, H El Darsa, B Anouti, D Mukherji, S Temraz, R Raslan, A Tfayli, ... Asian Pacific journal of cancer prevention: APJCP 18 (10), 2809, 2017 | 76 | 2017 |
| The crosstalk between microbiome and immune response in gastric cancer R Nasr, A Shamseddine, D Mukherji, F Nassar, S Temraz International Journal of Molecular Sciences 21 (18), 6586, 2020 | 72 | 2020 |
| Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics D Mukherji, A Omlin, C Pezaro, A Shamseddine, J de Bono Cancer and Metastasis Reviews 33, 555-566, 2014 | 66 | 2014 |
| Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective … S Temraz, D Mukherji, ZAA Farhat, R Nasr, M Charafeddine, M Shahait, ... BMC urology 14, 1-6, 2014 | 61 | 2014 |
| Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European urology 83 (3), 267-293, 2023 | 59 | 2023 |
